Skip to main content
  • Notice of Privacy Incident
  • Medicaid Provider Termination Alert: Revalidation deadlines are approaching. Failure by providers to revalidate will lead to termination and payment suspension. Check your account now at https://impact.illinois.gov/ to learn if your required revalidation is due this month. More revalidation information here.
Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: December 19, 2012

Drug Name Review Type Class Manufacturer
Stribild New Drug Initial Review HIV Gilead
Bydureon New Drug Initial Review Incretin Mimetics � GLP-1 Analog Amylin
Qnasl New Drug Appeal Intranasal Steroid Teva
Pradaxa PDL Appeal Direct Thrombin Inhibitor Boehringer-Ingelheim